About Daniel Goldsmith
Daniel Goldsmith is a director at Klinic.
Daniel Goldsmith reports to the SEC as a director or officer of 1 public company: Instructure (INST).
Daniel Goldsmith first appears on SEC filings in 2018.
Experience
This experience comes from Daniel Goldsmith's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Goldsmith in the role, so the role may have started earlier or lasted longer.
Klinic Inc Current
Director
2026 – Present · Frisco, TX
An online platform connecting patients with independent healthcare practitioners.
PC
Proofpoint Capital Current
Co-Founder & Partner
2025 – Present
LH
Lin Health Current
Board Member
2025 – Present
AR
Artera Current
Board Member
2021 – Present
TE
Tendo Current
Chairman
2020 – Present
GL
GoldsmithLink Advisors & Holdings, LLC Current
Founding Partner
2020 – Present
VE
Veho Current
Investor, Board Member, Advisor
2019 – Present
OS
Ostro
Strategic Advisor
2021 – 2026
BR
BrightInsight
Board Member
2020 – 2026
NU
Nuvolo
Investor and Board Member
2018 – 2023
II
Instructure Inc.
President and CEO (2018 – 2020)
Director
2018 – 2020 · Public company (INST)
LI
LiquidHub
Advisory Board Member
2014 – 2018
VS
Veeva Systems
Executive Vice President
2010 – 2018
IB
IBM
Partner
2002 – 2010
PR
PriceWaterhouseCoopers
Associate Partner
2000 – 2002
AC
Accenture
Manager
1997 – 2000
Key Colleagues at Startups
The people Daniel Goldsmith works with at each company, as listed on that company's latest Form D.
Klinic Inc · Form D, Jun 5, 2026
IG
Ilya Golubovich
Director
AB
Avish Bhama
Founder & CEO, director